Jurka Kidrič

514 total citations
16 papers, 436 citations indexed

About

Jurka Kidrič is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Jurka Kidrič has authored 16 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Microbiology and 4 papers in Immunology. Recurrent topics in Jurka Kidrič's work include Antimicrobial Peptides and Activities (5 papers), Chemical Synthesis and Analysis (4 papers) and Biochemical and Structural Characterization (4 papers). Jurka Kidrič is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Chemical Synthesis and Analysis (4 papers) and Biochemical and Structural Characterization (4 papers). Jurka Kidrič collaborates with scholars based in Slovenia, Croatia and Austria. Jurka Kidrič's co-authors include Primož Pristovšek, Roman Jerala, Eva Žerovnik, Vito Türk, Andreja Majerle, D. Hadži, Iztok Jože Košir, Krisztina Fehér, László Szilágyi and Janez Mavri and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Jurka Kidrič

16 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurka Kidrič Slovenia 10 208 122 109 102 46 16 436
Sophia Hartung Germany 9 574 2.8× 59 0.5× 80 0.7× 42 0.4× 21 0.5× 11 757
Dennis C. Young United States 7 399 1.9× 78 0.6× 32 0.3× 55 0.5× 48 1.0× 8 630
Sarah A. Overall United States 10 185 0.9× 72 0.6× 116 1.1× 41 0.4× 17 0.4× 14 323
Adriaan W. Tuin Netherlands 8 211 1.0× 40 0.3× 63 0.6× 28 0.3× 89 1.9× 14 418
Kaitlin Schaefer United States 14 499 2.4× 46 0.4× 23 0.2× 115 1.1× 100 2.2× 18 793
Xavier Gallet France 11 632 3.0× 183 1.5× 112 1.0× 26 0.3× 50 1.1× 18 825
Sanjay S. Khandekar United States 15 335 1.6× 23 0.2× 207 1.9× 55 0.5× 182 4.0× 22 749
William F. Walkenhorst United States 12 543 2.6× 349 2.9× 90 0.8× 26 0.3× 78 1.7× 15 742
Milon Mondal Netherlands 15 545 2.6× 82 0.7× 26 0.2× 88 0.9× 297 6.5× 22 790
Christopher M. Barbieri United States 21 1.2k 5.6× 70 0.6× 31 0.3× 84 0.8× 86 1.9× 33 1.4k

Countries citing papers authored by Jurka Kidrič

Since Specialization
Citations

This map shows the geographic impact of Jurka Kidrič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurka Kidrič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurka Kidrič more than expected).

Fields of papers citing papers by Jurka Kidrič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurka Kidrič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurka Kidrič. The network helps show where Jurka Kidrič may publish in the future.

Co-authorship network of co-authors of Jurka Kidrič

This figure shows the co-authorship network connecting the top 25 collaborators of Jurka Kidrič. A scholar is included among the top collaborators of Jurka Kidrič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurka Kidrič. Jurka Kidrič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pristovšek, Primož, Krisztina Fehér, László Szilágyi, & Jurka Kidrič. (2005). Structure of a Synthetic Fragment of the LALF Protein When Bound to Lipopolysaccharide. Journal of Medicinal Chemistry. 48(5). 1666–1670. 21 indexed citations
2.
Pristovšek, Primož & Jurka Kidrič. (2004). The Search for Molecular Determinants of LPS Inhibition by Proteins and Peptides. Current Topics in Medicinal Chemistry. 4(11). 1185–1201. 33 indexed citations
3.
Stare, Jernej, Aneta Jezierska, Gabriela Ambrožič, et al.. (2004). Density Functional Calculation of the 2D Potential Surface and Deuterium Isotope Effect on 13C Chemical Shifts in Picolinic Acid N-Oxide. Comparison with Experiment. Journal of the American Chemical Society. 126(13). 4437–4443. 39 indexed citations
4.
Majerle, Andreja, Jurka Kidrič, & Roman Jerala. (2000). Bacterial expression and refolding of different fragments of human CD14. Pflügers Archiv - European Journal of Physiology. 439(S1). r109–r110. 1 indexed citations
5.
Majerle, Andreja, Jurka Kidrič, & Roman Jerala. (2000). Production of stable isotope enriched antimicrobial peptides in Escherichia coli: An application to the production of a 15N-enriched fragment of lactoferrin. Journal of Biomolecular NMR. 18(2). 145–151. 34 indexed citations
6.
Kidrič, Jurka, et al.. (1999). Lapstatin, a new aminopeptidase inhibitor produced by Streptomyces rimosus , inhibits autogenous aminopeptidases. Archives of Microbiology. 171(6). 397–404. 18 indexed citations
7.
Pristovšek, Primož & Jurka Kidrič. (1999). Solution Structure of Polymyxins B and E and Effect of Binding to Lipopolysaccharide: An NMR and Molecular Modeling Study. Journal of Medicinal Chemistry. 42(22). 4604–4613. 154 indexed citations
8.
Majerle, Andreja, Jurka Kidrič, & Roman Jerala. (1999). Expression and Refolding of Functional Fragments of the Human Lipopolysaccharide Receptor CD14 in Escherichia coli and Pichia pastoris. Protein Expression and Purification. 17(1). 96–104. 9 indexed citations
9.
Kidrič, Jurka, et al.. (1998). Influence of glycation on cis/trans isomerization and tautomerization in novel morphiceptin-related Amadori compounds. Glycoconjugate Journal. 15(6). 563–570. 12 indexed citations
10.
Jerala, Roman, Eva Žerovnik, Jurka Kidrič, & Vito Türk. (1998). pH-induced Conformational Transitions of the Propeptide of Human Cathepsin L. Journal of Biological Chemistry. 273(19). 11498–11504. 87 indexed citations
11.
Pristovšek, Primož & Jurka Kidrič. (1997). NMR and molecular dynamics study of muroctasin—Implications for the bioactive conformation. Biopolymers. 42(6). 659–671. 3 indexed citations
12.
Pristovšek, Primož, Jurka Kidrič, & D. Hadži. (1997). Proposal of a 3D Peptide Pharmacophore of Muramyl Dipeptide-Type Immunostimulants. 2. Computer Docking to a Model Protein Binding Site. Journal of Chemical Information and Computer Sciences. 37(6). 977–984. 1 indexed citations
13.
Pristovšek, Primož, Jurka Kidrič, & D. Hadži. (1997). Proposal of a 3D Peptide Pharmacophore of Muramyl Dipeptide-Type Immunostimulants. 1. Conformational Search of Active and Inactive Analogues. Journal of Chemical Information and Computer Sciences. 37(6). 971–976. 2 indexed citations
14.
Kojić‐Prodić, Biserka, et al.. (1995). Synthesis and conformational analysis of the Amadori compound N-(2,3:4,5-di-O-isopropylidene-1-deoxy-β-d-fructopyranos-1-yl)-l-tyrosine benzyl ester. Carbohydrate Research. 279. 21–39. 3 indexed citations
15.
Pristovšek, Primož, Jurka Kidrič, & D. Hadži. (1995). Bioactive Conformations of Small Peptides: A Method for Selection of Candidates Based on Conformations of Active and Inactive Analogs and Its Application to Muramyl Dipeptide. Journal of Chemical Information and Computer Sciences. 35(3). 633–639. 10 indexed citations
16.
Kikelj, D., Jurka Kidrič, Primož Pristovšek, et al.. (1992). Preparation of diastereomerically pure immunologically active carbocyclic nor-muramyldipeptide analogues. Tetrahedron. 48(28). 5915–5932. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026